According to the announcement from Mailyard (600107.SH), the company expects to report a net loss attributable to shareholders of the listed company ranging from 86 million yuan to 44 million yuan for the fiscal year 2024.

During the reporting period, due to the disposal of the equity of its subsidiary Qinghai Zhongyou Health Huijia Pharmaceutical Chain Co., Ltd., the period included in the consolidated financial statements is from January to April 2024, resulting in a decrease in revenue costs in the pharmaceutical sector compared to the same period last year; due to intense market competition, the revenue costs in the clothing sector have also reduced compared to the same period last year, leading to a decline in the overall gross profit margin of the company; additionally, the coal trade incurred a loss of approximately 8 million yuan due to not having fully received coal supply subsidies